PROMIS NEUROSCIENCES INC. Cash and Restricted Cash
PROMIS NEUROSCIENCES INC. (PMN) had Cash and Restricted Cash of $53.43 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $53.43M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $63.81M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.12M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.40M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $53.43M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $63.81M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $6.12M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $15.40M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.51M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $8.36M 10-Q · filed 2026-05-12 |
| 2024-12-31 | $13.29M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $21.54M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $992.46K 10-Q · filed 2025-08-13 |
| 2024-03-31 | $2.50M 10-Q · filed 2025-05-12 |
| 2023-12-31 | $12.60M 10-K · filed 2026-03-25 |
| 2023-09-30 | $16.87M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $1.22M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $3.33M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $5.88M 10-K · filed 2025-03-31 |
| 2022-09-30 | $3.92M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $8.90M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $13.75M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $16.94M 10-K · filed 2024-04-01 |
| 2021-09-30 | $20.90M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $5.57M 10-Q · filed 2022-08-12 |
| 2020-12-31 | $806.89K 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |